NASDAQ:XERS | Income Statement | Xeris Biopharma Holdings, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$92.1M$10.67M$61.04M$5.17M$0.00-$31.1M-$0.18-$0.18172,823,455172,823,455
2026-03-31$83.13M$8.78M$53.14M$7.92M$0.00$2.23M$0.01$0.01170,523,208177,631,154
2025-12-31$85.81M$7.87M$47.5M$16.77M$0.00$11.08M$0.07$0.071,865,73114,183,253
2025-09-30$74.38M$7.48M$46.46M$6.73M$0.00$621,000.00$0.00$0.00163,649,932177,617,307
2025-06-30$71.54M$8.06M$44.39M$4.48M$0.00-$1.93M-$0.01-$0.01159,459,413159,459,413
2025-03-31$60.12M$7.75M$44.02M-$3.09M$0.00-$9.22M-$0.06-$0.06152,445,935152,445,935
2024-12-31$60.1M$6.09M$40.14M$1.68M$0.00-$5.11M-$0.03-$0.03810,560810,560
2024-09-30$54.27M$5.89M$44.97M-$12.89M-$3.32M-$15.74M-$0.11-$0.11148,993,823148,993,823
2024-06-30$48.07M$5.76M$39.99M-$8.19M$749,000.00-$15.01M-$0.10-$0.10148,345,549148,345,549
2024-03-31$40.64M$7.82M$38.38M-$14.25M$307,000.00-$18.98M-$0.14-$0.14140,513,907140,513,907
2023-12-31$44.39M$6.38M$37.57M-$9.84M-$236,000.00-$13.39M-$0.09-$0.09151,655151,655
2023-09-30$48.32M$5.03M$37.29M-$4.91M-$338,000.00-$12.19M-$0.09-$0.09138,059,781138,059,781
2023-06-30$38.01M$6.09M$37.64M-$15.98M-$675,000.00-$19.84M-$0.14-$0.14137,338,071137,338,071
2023-03-31$33.2M$4.84M$33.61M-$13.28M$0.00-$16.83M-$0.12-$0.12137,142,565137,142,565
2022-12-31$33.14M$4.96M$34.36M-$15.17M-$338,000.00-$12.93M-$0.10-$0.10120,518120,518
2022-09-30$29.73M$6.04M$34.49M-$18.78M-$339,000.00-$21.83M-$0.16-$0.16135,951,761135,951,761
2022-06-30$25.31M$3.72M$32.98M-$18.92M-$339,000.00-$26.19M-$0.19-$0.19135,529,968135,529,968
2022-03-31$22.07M$6.25M$35.91M-$29.07M-$408,000.00-$33.71M-$0.25-$0.25135,032,782135,032,782
2021-12-31$21.43M$10.08M$54.18M-$48.27M$0.00-$50.79M-$0.44-$0.4414,304,51014,304,510
2021-09-30$11.06M$3.22M$7.84M$5.66M$26.54M$32.2M-$24.36M$0.00-$26.01M-$0.39-$0.3966,497,59366,497,593
2021-06-30$8.91M$5.38M$25.93M-$25.79M$0.00-$27.52M-$0.41-$0.4166,367,12566,367,125
2021-03-31$8.05M$4.03M$19.08M-$16.74M$0.00-$18.41M-$0.30-$0.3061,245,22061,245,220
2020-12-31$7.09M$5.11M$18M-$19.34M$0.00-$21.86M3,647,194
2020-09-30$9.4M$2.83M$6.62M$3.88M$16.48M$20.36M-$13.74M$0.00-$16M46,145,116
2020-06-30-$24.1M
2020-03-31-$29.18M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$291.85M$31.17M$182.37M$24.9M$554,000.00$0.00$554,000.00$0.00$0.00160,425,198172,742,720
2024-12-31$203.07M$25.56M$163.48M-$33.65M-$57.1M-$2.27M-$54.84M-$0.37-$0.37146,772,758146,772,758
2023-12-31$163.91M$22.34M$146.1M-$44.01M-$63.5M-$1.25M-$62.26M-$0.45-$0.45137,674,857137,674,857
2022-12-31$110.25M$20.97M$137.75M-$81.94M-$96.08M-$1.42M-$94.66M-$0.70-$0.70135,628,721135,628,721
2021-12-31$49.59M$25.16M$125.72M-$115.16M-$122.73M$0.00-$122.73M-$1.55-$1.5579,027,06279,027,062
2020-12-31$20.16M$20.92M$73.73M-$83.55M-$110,000.00-$91.14M42,642,901

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.